Recently visited unit

Optional shares

name	Price (yuan)	Rise and fall
The following are popular stocks

Please check the self selected shares first Sign in

name	Price (yuan)	Rise and fall

Management of self selected shares

^_^ sign out

join remind View in APP

Hanyu Pharmaceutical (300199.SZ)

Questioning stocks

@change@

@changeP@

@now@

Limit: @ up_limit@

Limit: @ down_limit@

Suspension

@date@ @time@

Temporary suspension

Today:	@open@	Volume:	@volume@	Amplitude:	@swing@
Maximum:	@high@	Turnover:	@amount@	turnover rate:	@turnover@
Minimum:	@low@	Total Market Value:	@fixTotalShare@	P/B ratio:	@pb@
Received yesterday:	@preClose@	Circulation value:	@cvs@	P/E ratio^TTM ：	@pe@
Total share capital:	@zgb@	Circulating shares:	@ltgb@

Information mine:

The browser version is too low to view the multi null inversion

Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox 、 Google

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Time-sharing

Day K

Week K

Month K

K line

Reinstatement K line

Technical drawings

Trend comparison:

market index

Shanghai Stock Exchange Index

Shenzhen Stock Index

CSI 300

compare

Also concerned:

5th gear disc opening

Live broadcast of famous teachers

Commission ratio -- Abandonment --
Selling ⑤	--	--
Sell ④	--	--
Selling ③	--	--
Sell ②	--	--
Selling ①	--	--
deal	--
Buy ①	--	--
Buy ②	--	--
Buy ③	--	--
Buy ④	--	--
Buy ⑤	--	--
Outer disc -- Inner disc --

In case of a key big order, the main force may**

Quickly use level2 to view details>

Pen by pen

Large order

Price sharing

Time-sharing

time	Price (yuan)	Measurement (hand)	nature

time	Price (yuan)	Measurement (hand)	nature

Transaction price (yuan)	Trading volume (hand)	Proportion (%)

time	Transaction price (yuan)	Trading volume (hand)

Scan code subscription

Investment research report

Questioning stocks

Live broadcast of stock market

Product entry: Sina Finance APP - Stocks - Investment Research Report

Product entrance: Sina Finance APP - stock - free question

money flow

Main compass Indicator description

Main and retail investors' capital flow
	Main buy	Main sales	Purchase by retail investors	Retail sales
Amount (10000 yuan)	@mainIn@	@mainOut@	@retailIn@	@retailOut@
proportion	@mainInP@	@mainOutP@	@retailInP@	@retailOutP@

Loose bill

Small order

Large order

Extra large order

Net inflow of classified funds
	Loose bill	Small order	Large order	Extra large order
Net inflow (10000 yuan)	@r3_r_in@	@r2_r_in@	@r1_r_in@	@r0_r_in@
Proportion in the flow board	@r3_p_svs@	@r2_p_svs@	@r1_p_svs@	@r0_p_svs@
Proportion in turnover rate	@r3_p_turnover@	@r2_p_turnover@	@r1_p_turnover@	@r0_p_turnover@

(06-06) Wuhan's first large-scale liquid cooled energy storage power station can charge 100000 kWh in 2 hours
(06-06) Hanyu Pharmaceutical fell 5.09% to 9.7 yuan/share
(06-05) Chinese polypeptide CDMO, more and more able to play?
(06-05) Bai Jiepin Shares | Lianyang
(06-05) AI pharmaceutical penetration is expected to increase
(06-04) Weekly medical highlights (May 27 June 2)

research report

Company research

Hanyu Pharmaceutical (300199): Xinguan prevents race track from seizing

Industry research

Big V view

Hanyu Pharmaceutical Stock Exchange

title click reply Final reply

[The concept of diet pills was active in the afternoon, and Hanyu Pharmaceutical rose by more than 10% one hundred and sixty-two zero 06-07 13:12
[Wuhan's first large-scale liquid cooled energy storage power station can one hundred and eighty-seven one 06-06 11:21
I'm disappointed in Hanyu Pharmaceutical (SZ300199) [I one hundred and fifty-six zero 06-06 10:06
despair one hundred and forty-four zero 06-06 10:06
300199, product in hand three hundred and seventy-nine zero 06-04 08:26
The performance of Hanyu Pharmaceutical is still very good three hundred and forty-eight zero 06-04 08:15
The concept of weight-loss drugs initially fell two hundred and thirty zero 06-03 09:41
Hanyu Pharmaceutical fell 12.48% at the opening four hundred and fourteen zero 06-03 09:26

See who runs fast next week four hundred and eleven zero 06-01 13:55
[Hanyu Pharmaceutical's inquiry letter on receiving the annual report: request to explain the company 20 nine hundred and eight zero 05-31 15:49
Hanyu Pharmaceutical is really playing with the logic of the scalping of Simei seven hundred and thirty zero 05-29 09:45
[Hanyu Pharmaceutical: Sign with Sansheng Mandi for Smeglutide injection six hundred and ninety-seven zero 05-28 19:43
[Hanyu Pharmaceutical: Ganirek Acetate Injection was approved for marketing] nine hundred and sixty zero 05-27 15:48
Why didn't anyone come out and say something four hundred and thirty-three zero 05-23 09:48
The number of diabetic patients is 140 million, which continues to rise significantly eight hundred and seventy-three zero 05-21 16:26
[Hanyu Pharmaceutical: Signed with the Management Committee of Zhongguancun Science City nine hundred and twenty-nine zero 05-20 19:07

Company research

Hot data

Adjacent ranking

Top 10 in the industry

Financial ratios

Adjacent ranking

Top 10 in the industry

Investment rating of research institutions

In the last 60 days Hanyu Pharmaceutical (sz300199) rating was released in three research reports, and the comprehensive rating is as follows:

Hot columns

Industry comparison

name	Price (yuan)

expand all Pack All

Investment instruments

Market trend

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

corporate name:

Shenzhen Hanyu Pharmaceutical Co., Ltd

Main business:

Chemical pharmaceuticals and medical devices.

Telephone: 0755-26588036

Fax: 0755-26588022

Date of establishment: 2003-04-02

Listing date: 2011-04-07

Legal representative: Zeng Shaogui

general manager:

Registered capital: 883.241 million yuan

Issue price: 30.190 yuan

Latest total share capital: 883241336 shares

Latest outstanding shares: 6660338130000001 shares

Segment: GEM Shenzhen A-share Shanghai and Shenzhen A-share Shenzhen Composite Index Manufacturing index Pharmaceutical index Pharmaceuticals Shenzhen Stock Connect Shenzhen Stock Connect Innovative medicine Pharmaceutical Biology Chemical pharmacy

Financial summary

2024-03

2023-12

2023-09

2023-06

2023-03

Earnings per share	-0.0160 yuan	-RMB 0.5818	-RMB 2044	-0.0386 yuan	0.0211 yuan
net asset value per share	0.8468 yuan	0.8591 yuan	1.2731 yuan	1.4277 yuan	1.4721 yuan
Net operating cash flow per share	0.0172 yuan	-0.0040 yuan	-0.0615 yuan	-0.0426 yuan	-0.0425 yuan
Return on net assets	-1.89%	-67.72%	-16.06%	-2.71%	1.43%
Undistributed profit per share	-1.9228 yuan	-1.9065 yuan	-1.5291 yuan	-1.3633 yuan	-1.3036 yuan
Capital reserve per share	1.6607 yuan	1.6569 yuan	1.6919 yuan	1.6802 yuan	1.6704 yuan

Date of announcement	Allocation scheme
2018-04-12	10 pairs, 2 yuan
2017-06-16	10 pairs1 yuan
2016-05-27	10 pies 0.25 yuan
2015-04-08	10 pairs1 yuan to 10 shares
2013-04-18	10 pairs1 yuan to 10 shares

Circulation shareholders

2024-03

2023-12

2023-09

Name of shareholders	Shareholding (%)	Increase or decrease
Li Xiulan	five point three zero four	reduce one's shares in a listed company
Shenzhen Hi tech Investment&Marketing Co., Ltd	four point eight nine five	New progress
Zeng Shaogui	one point eight one two	reduce one's shares in a listed company
Zeng Shaoqiang	one point three three four	Overweight
Quanzhou Fengyong Equity	zero point nine four four	Unchanged
Zeng Shaobin	zero point eight one five	New progress
HKSCC has	zero point six seven six	Overweight
Ma Jianji	zero point six three five	Unchanged
Bank of Communications shares have	zero point six two five	New progress
Hu Liyun	zero point five eight one	Overweight

Name of shareholders	Shareholding (%)	Increase or decrease
Li Xiulan	six point two nine three	reduce one's shares in a listed company
Zeng Shaogui	two point two three five	Unchanged
Wang Xiaoke	two point one eight six	New progress
Quanzhou Fengyong Equity	zero point nine four four	reduce one's shares in a listed company
Ma Jianji	zero point six three five	Unchanged
HKSCC has	zero point six one five	reduce one's shares in a listed company
Zeng Shaoqiang	zero point five seven eight	Unchanged
Liu Junbin	zero point five seven one	Overweight
Hu Liyun	zero point five four eight	Overweight
Zhang Zengrong	zero point five zero four	New progress

Name of shareholders	Shareholding (%)	Increase or decrease
Li Xiulan	six point six three one	Unchanged
Zeng Shaogui	two point two three five	reduce one's shares in a listed company
Quanzhou Fengyong Equity	one point nine zero two	Unchanged
HKSCC has	one point four nine eight	Overweight
Zha Yiding	one point one eight one	New progress
Ma Jianji	zero point six three five	Unchanged
Zeng Shaoqiang	zero point five seven eight	Unchanged
Hu Liyun	zero point five two two	Overweight
Liu Junbin	zero point five one seven	Unchanged
Zhang Tianxu	zero point four four eight	Unchanged

user name:
Password:
	Record login status for one month
	Sign in Retrieve password Login Help Not yet a member of Sina? New User Registration

Hanyu Pharmaceutical (300199.SZ)

Investment research report

Live broadcast of stock market

money flow

Company Information

research report

Big V view

Company No

Hanyu Pharmaceutical Stock Exchange

Company research

Hot data

Financial ratios

Investment rating of research institutions

Hot columns

Industry comparison

Investment instruments

Market trend

Company information

Distribution

Equity shareholders

Company announcement

financial data

Major events

Company Profile

Financial summary

Dividend distribution

Circulation shareholders

Shareholding ratio of circulating shareholders